QGEN
Qiagen N.V. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -3.2% · net new positions -5.9% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 23.33M | -10.3% | $1.04B | 0.2% | ▼ Trim | 3 | SEC ↗ ×9 |
| 2 | The Vanguard Group ✦ (passive) | 9.42M | +1.9% | $420.40M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | T. Rowe Price ✦ | 7.52M | +26.7% | $336.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 5.31M | -2.3% | $237.24M | 0.0% | ▼ Trim | 2 | SEC ↗ ×12 |
| 5 | Morgan Stanley ✦ | 4.38M | n/a | $195.55M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 6 | State Street Global Advisors ✦ (passive) | 2.17M | +1.0% | $96.74M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 1.54M | n/a | $68.95M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | JPMorgan Chase ✦ | 1.48M | n/a | $66.18M | 0.0% | n/c | 1 | SEC ↗ ×24 |
| 9 | Geode Capital Management ✦ (passive) | 1.10M | +3.1% | $49.19M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 10 | Marshall Wace ✦ | 870.85K | -15.6% | $38.62M | 0.0% | ▼ Trim | 4 | SEC ↗ ×3 |
| 11 | Fidelity (FMR) ✦ | 478.06K | -13.7% | $21.17M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 12 | Citadel Advisors ✦ | 301.03K | -24.9% | $13.45M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 13 | Gotham Asset Management ✦ | 273.67K | +308.1% | $12.23M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 108.81K | -22.6% | $4.86M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 15 | Two Sigma Investments ✦ | 36.30K | +7.1% | $1.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 29.74K | -96.3% | $1.33M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 10.71K | +3.7% | $473,697 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Norges Bank | $158.73M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 7 holders, 1.07M shares, $43.54M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.